Compare AU

Compare NUGG vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

VanEck Gold Bullion ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are NUGG and DRUG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

NUGG

DRUG

Popularity

Low

Low

Pearlers invested

30

63

Median incremental investment

$533.00

$967.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,006.80

$1,875.72

Average age group

> 35

26 - 35


Key Summary

NUGG

DRUG

Strategy

NUGG.AX was created on 2022-05-12 by VanEck. The fund's investment portfolio concentrates primarily on gold commodities. NUGG.AX gives investors an investment in Australian sourced gold.

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

VanEck Gold Bullion ETF (100 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.25 %

0.57 %


Key Summary

NUGG

DRUG

Issuer

VanEck

BetaShares

Tracking index

LBMA Gold Price AM - AUD - Benchmark Price Return

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.25 %

0.57 %

Price

$41.95

$8.12

Size

$86.275 million

$191.120 million

10Y return

N/A

N/A

Annual dividend/ distribution yield (5Y)

- %

1.90 %

Market

ASX

ASX

First listed date

06/12/2022

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

NUGG

DRUG

Popularity

Low

Low

Pearlers invested

30

63

Median incremental investment

$533.00

$967.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,006.80

$1,875.72

Average age group

> 35

26 - 35


Pros and Cons

NUGG

DRUG

Pros

  • Lower management fee

  • Higher exposure to US market

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Lower price growth

  • Lower distribution yield

  • Higher management fee

NUGG

DRUG

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home